You have no items in your shopping cart.
Laboratory research use only. Not for human or animal consumption.
RSS

New products

Display per page
Tirzepatide

Tirzepatide

A dual GIP/GLP-1 medication class item reviewed for appetite, weight, and glucose management.

AppetiteWeight
More library details

Research context

  • Acts through incretin pathways that influence satiety and glucose handling.
  • Often produces stronger appetite effects than GLP-1-only approaches for some users.

Review before use

  • Review prescription source, escalation, GI tolerance, and lean-mass preservation plan.
  • Keep protein, resistance training, and constipation prevention visible in the app.

Evidence notes

  • Dual GIP/GLP-1 receptor agonist medication class studied for glucose control, appetite, and body-weight outcomes.
  • Clinical review should include GI tolerance, gallbladder/pancreatitis risk, and lean-mass preservation.

Cautions

  • Medical supervision is required.
  • Discuss pancreatitis, gallbladder, thyroid cancer history, and medication interactions.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

Call for pricing
Retatrutide

Retatrutide

A triple receptor agonist research/clinical-trial class item discussed for appetite, body weight, and metabolic effects.

WeightMetabolic
More library details

Research context

  • Targets GLP-1, GIP, and glucagon pathways.
  • Reviewed for strong body-weight and metabolic effects in research contexts.

Review before use

  • Clarify availability, regulatory status, trial data, and medical appropriateness.
  • Track GI tolerance, hydration, weight rate, and strength preservation.

Evidence notes

  • Investigational triple-receptor agonist class item studied for GLP-1, GIP, and glucagon pathway activity.
  • Clinical studies have evaluated effects on body weight, glucose handling, and cardiometabolic markers.

Cautions

  • Not a casual or unsupervised compound.
  • Use legitimate medical channels only.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

Call for pricing
CJC-1295

CJC-1295

A growth-hormone releasing hormone analog commonly reviewed for GH pulse support.

GHRecovery
More library details

Research context

  • Extends growth-hormone releasing hormone signaling depending on form.
  • Often paired with a GHRP such as ipamorelin.

Review before use

  • Review IGF-1, glucose, sleep apnea risk, cancer history, and edema symptoms.
  • Clarify DAC versus no-DAC form before any protocol discussion.

Evidence notes

  • GH-axis compounds are discussed around growth-hormone and GHRH signaling and require lab-guided review.
  • Evidence and risk review should include IGF-1, glucose, edema, sleep apnea, and cancer-history considerations.

Cautions

  • Hormone-pathway agents need lab monitoring.
  • Avoid if contraindicated by personal cancer risk or unmanaged metabolic disease.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$35.00
Ipamorelin

Ipamorelin

A growth-hormone secretagogue often discussed as a cleaner GH pulse option than older GHRPs.

SleepGH
More library details

Research context

  • Stimulates GH release through ghrelin receptor signaling.
  • Commonly reviewed with CJC-1295 for recovery and sleep-focused protocols.

Review before use

  • Review appetite, glucose, IGF-1, and sleep apnea considerations.
  • Confirm timing and whether it conflicts with nutrition schedule.

Evidence notes

  • GH secretagogue research focuses on ghrelin-receptor signaling and growth-hormone pulse support.
  • Risk review should include appetite, glucose, IGF-1, edema, sleep apnea, and hormone-sensitive history.

Cautions

  • Not appropriate for unsupervised hormone manipulation.
  • Discuss swelling, tingling, glucose issues, and headache symptoms.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$28.00
Sermorelin

Sermorelin

A GHRH analog used in some clinics for growth-hormone stimulation review.

GHSleep
More library details

Research context

  • Supports endogenous GH signaling rather than replacing GH.
  • Often evaluated through IGF-1 and symptom tracking.

Review before use

  • Review baseline labs, sleep apnea, glucose control, and expected monitoring schedule.
  • Compare with CJC/ipamorelin options with a clinician.

Evidence notes

  • GHRH analog research and clinical use focus on endogenous growth-hormone stimulation under medical review.
  • Monitoring commonly centers on IGF-1, sleep apnea risk, glucose, edema, and expected clinical goals.

Cautions

  • Hormone-axis protocols require medical supervision.
  • Do not use with unexplained symptoms or active malignancy concerns.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$43.00
Kisspeptin-10

Kisspeptin-10

A reproductive-axis peptide discussed for LH/FSH signaling and hormone evaluation.

HormoneFertility
More library details

Research context

  • Stimulates upstream reproductive hormone signaling.
  • Reviewed in testosterone, fertility, and reproductive-axis contexts.

Review before use

  • Review LH, FSH, testosterone, estradiol, fertility goals, and medications.
  • Clarify whether symptoms are thyroid, sleep, stress, or gonadal-axis related.

Cautions

  • Requires lab-guided medical oversight.
  • Do not combine with hormone therapy without clinician review.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$40.00

FOR RESEARCH USE ONLY. The products offered on this site are intended solely for in-vitro laboratory research and development use. These statements and products have not been evaluated by the U.S. Food and Drug Administration (FDA). These products are not drugs, foods, dietary supplements, or cosmetics, and are not intended to diagnose, treat, cure, or prevent any disease or medical condition. They are not intended for human or animal consumption, ingestion, injection, or any in-vivo or clinical use of any kind. By purchasing from RevPep, you confirm that you are a qualified researcher or institution and that you will handle, store, and dispose of these materials in accordance with all applicable laws, regulations, and institutional safety protocols.